NCT00649714View on ClinicalTrials.gov

Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Healthy
Interventions
DRUG

Zonisamide Capsules 100 mg

100mg, single dose fed

DRUG

Zonegran® Capsules 100 mg

100mg, single dose fed

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00649714 - Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg | Biotech Hunter | Biotech Hunter